A pill for infertility: Oxolife’s non-hormonal oral drug raises embryo implantation rate, pregnancy rates and live birth … [Read more...] about A pill for infertility: Oxolife’s non-hormonal oral drug raises embryo implantation rate, pregnancy rates and live birth rate in women undergoing IVF and ICSI, data being presented at ESHRE shows
News
OXOART2, selected as one of the most exciting pieces of research presented at ESHRE 40th annual meeting celebrated in Amsterdam
Novel treatment improves embryo implantation and live birth rates in infertile women undergoing IVF and ICSI New … [Read more...] about OXOART2, selected as one of the most exciting pieces of research presented at ESHRE 40th annual meeting celebrated in Amsterdam
Oxolife will present the first OXO-001 results at the European Congress of Human Reproduction (ESHRE)
OXOLIFE is thrilled to announce that on Monday, July the 8th, our CEO, Agnès Arbat Arbat, will be presenting the … [Read more...] about Oxolife will present the first OXO-001 results at the European Congress of Human Reproduction (ESHRE)
Oxolife Appoints International Fertility Experts to its Scientific Advisory Board
Barcelona, Spain – 13th November 2023, Oxolife, the specialist biotech focused on enhancing embryo implantation in women … [Read more...] about Oxolife Appoints International Fertility Experts to its Scientific Advisory Board
OXO-001, for embryo implantation makes headlines in the Daily News!
Oxolife and its phase II asset OXO-001 for embryo implantation have been featured in the UK's highest circulated daily … [Read more...] about OXO-001, for embryo implantation makes headlines in the Daily News!
Oxolife in the radio
We are delighted to share the interview to our CEO Agnès Arbat on #Lideratges, Ariadna’s Belver Comin program, where … [Read more...] about Oxolife in the radio
At OXOLIFE we are celebrating!!
After a year since the start of our clinical trial and after the last milestone of end of recruitment, we want to share … [Read more...] about At OXOLIFE we are celebrating!!
Oxolife attend to ESHRE Congress 2022
These days the OXOLIFE team is in Milan (Italy) at European Society of Human Reproduction and Embryology (ESHRE) … [Read more...] about Oxolife attend to ESHRE Congress 2022
At @OXOLIFE we are celebrating!
After 9 months of recruiting women who are looking for pregnancy, we have finally passed our milestone with 403 patients … [Read more...] about At @OXOLIFE we are celebrating!
Oxolife in the News
Our CEO Agnes Arbat is interviewed at IB radio to talk about our OXOART2 Clinical trial. She explains the potential of … [Read more...] about Oxolife in the News